AXQ Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
AXQ Capital's AUPH Position: Q3 2026 in Review
AXQ Capital reduced its Aurinia Pharmaceuticals (AUPH) stake by 26% in Q3 2026, selling an estimated $58.9K and leaving 10,436 shares worth $169K. The position accounts for 0.02% of the portfolio, ranked #785.
AXQ Capital first reported a position in AUPH in Q2 2023 and has held it in 6 quarters since. The position peaked at $329K in Q4 2025. 276 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.
- AXQ Capital held 10,436 shares of Aurinia Pharmaceuticals worth $169K as of Q3 2026.
- AXQ Capital sold 3,691 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $58.9K.
- Aurinia Pharmaceuticals made up 0.02% of AXQ Capital's portfolio in Q3 2026, its #785 holding.
- AXQ Capital first reported a position in Aurinia Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
- AXQ Capital's Aurinia Pharmaceuticals position peaked at $329K in Q4 2025.
- 276 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.
Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.